Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Summary: GLP-1 receptor agonists do not directly cause irregular periods, but the significant weight loss they produce can temporarily affect menstrual regularity through metabolic and hormonal changes
By staying informed, regularly monitoring eye health, and working closely with a healthcare provider, the risks can be managed, ensuring that the benefits of these drugs outweigh the potential drawbacks
A temporary plateau (two to four weeks where weight fluctuates within a small range due to water retention, hormonal shifts, or muscle gain) differs from a true plateau, where weight and body composition remain unchanged for eight weeks or more
If results remain strong, the FDA could approve them within 2 to 4 years
US$ 23.93
US$ 26.64
US$ 22.06
